Metabolic or bariatric surgery Long-term effects of malabsorptive vs restrictive bariatric techniques on body composition and cardiometabolic risk factors

International Journal of Obesity

Volumn 34, Issue 9, 2010, Pages 1404-1414

  Lubrano, C ^a   Mariani, S ^a   Badiali, M ^b   Cuzzolaro, M ^a   Barbaro, G ^a   Migliaccio, S ^a   Genovesi, G ^a   Rossi, F ^a   Celanetti, M ^a   Fiore, D ^a   Pandolfo, M M ^a   Specchia, P ^a   Spera, G ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

body composition; cardiometabolic risk factors; restrictive and malabsorptive bariatric surgery

Indexed keywords

FIBRINOGEN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BARIATRIC SURGERY; BLOOD PRESSURE; BODY COMPOSITION; BODY MASS; BODY WEIGHT; BYPASS SURGERY; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOLLOW UP; GASTRIC BANDING; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; INFLAMMATION; INSULIN BLOOD LEVEL; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALABSORPTION; MALABSORPTIVE BILIOINTESTINAL BYPASS; MALE; METABOLISM; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; BARIATRIC SURGERY; BODY COMPOSITION; BODY MASS INDEX; CASE-CONTROL STUDIES; FEMALE; GASTROPLASTY; HUMANS; MALE; OBESITY; PROSPECTIVE STUDIES; TIME; WEIGHT LOSS;

EID: 77956688211     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2010.54     Document Type: Article

References (52)

1. Bult MJ, van Dalen T, Muller AF. Surgical treatment of obesity. Eur J Endocrinol 2008; 158: 135-145.
2. Haslam DW, James WP. Obesity. Lancet 2005; 366: 1197-1209.
3. Stevens VJ, Obarzanek E, Cook NR, Lee IM, Appel LJ, Smith West D et al. Long term weight loss and changes in blood pressure: results of the trials of hypertension prevention, phase II. Ann Intern Med 2001; 134: 1-11.
4. Dixon JB, Pories WJ, O'Brien PE, Schauer PR, Zimmet P. Surgery as an effective early intervention for diabesity: why the reluctance? Diabetes Care 2005; 28: 472-474.
5. Poobalan AS, Aucott LS, Smith WC, Avenell A, Jung R, Broom J. Long-term weight loss effects on all cause mortality in overweight/obese populations. Obesity Rev 2007; 8: 503-513.
6. De Maria EJ. Bariatric surgery for morbid obesity. N Engl J Med 2007; 356: 2176-2183.
7. Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004; 292: 1724-1737.
8. Rubino F, Gagner M. Potential of surgery for curing type 2 diabetes mellitus. Ann Surg 2002; 236: 554-559.
9. Levy P, Fried M, Santini F, Finer N. The comparative effects of bariatric surgery on weight and type 2 diabetes. Obes Surg 2007; 17: 1248-1256.
10. Vogel JA, Franklin BA, Zalesin KC, Trivax JE, Krause KR, Chengelis DL et al. Reduction in predicted coronary heart disease risk after substantial weight reduction after bariatric surgery. J Am Cardiol 2007; 99: 222-226.
11. Corradini SG, Eramo A, Lubrano C, Spera G, Cornoldi A, Grossi A et al. Comparison of changes in lipid profile after bilio-intestinal bypass and gastric banding in patients with morbid obesity. Obes Surg 2005; 15: 367-377.
12. Flum DR, Salem L, Elrod JA, Dellinger EP, Cheadle A, Chan L. Early mortality among Medicare beneficiaries undergoing bar-iatric surgical procedures. JAMA 2005; 294: 1903-1908.
13. NIH conference. Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel. Ann Intern Med 1991; 115: 956-961.
14. Marcus MD, Kalarchian MA. Courcoulas AP Psychiatric evaluation follow-up of bariatric surgery patients. Am J Psychiatry 2009; 166: 285-291.
15. Grundy SM, Brewer HM, Cleeman JI, Smith SC, Lenfant C. Definition of Metabolic Syndrome Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004; 109: 433-438.
16. Mechanick JI, Kushner RF, Sugerman HJ, Gonzalez-Campoy JM, Collazo-Clavell ML, Spitz AF et al. American Association of Clinical Endocrinologists, The Obesity Society, and American Society For Metabolic & Bariatric surgery medical guidelines for clinical practice for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient. Obesity 2009; 17 (s1): s1-s70.
17. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2000; 23 (Suppl. 1): S4-S19.
18. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
19. Andreoli A, Scalzo G, Masala S, Tarantino U, Guglielmi G. Body composition assessment by dual-energy X-ray absorptiometry (DXA). Radiol Med 2009; 114: 286-300.
20. Boorsma W, Snijder MB, Nijpels G, Guidone C, Favuzzi AMR, Mingrone G et al. Body composition, insulin sensitivity, and cardiovascular disease profile in healthy Europeans. Obesity 2008; 16: 2696-2701.
21. Rahman M, Temple J, Breitkopf C, Berenson A. Racial differences in body fat distribution among reproductive-aged women. Metab Clin Exp 2009; 58: 1329-1337.
22. Tsutomu D, Yukie Y, Yukie K, Akiko K, Tomoki K, Ichiro I. Difference in segmental lean and fat mass components between pre-and postmenopausal women. Menopause 2007; 14: 875-878.
23. Haasen G, Fagertum H, Tonstad S, Halse J. Leg fat mass as measured by dual X-ray absorptiometry (DXA) impacts insulin resistance differently in obese women versus men. Scand J Clin Lab Invest 2009; 69: 181-189.
24. Haasen G, Fagertun H, Halse J. Insulin resistance and dyslipidae-mia in obese premenopausal and postmenopausal women matched for leg/trunk fat mass ratio. Scand J Clin Lab Invest 2009; 69: 505-511.
25. Micheletto G, Mozzi E, Lattuada E, Lanni M, Perrini M, Caccialanza R et al. The biliointestinal bypass. Ann Ital Chir 2007; 78: 27-30.
26. Bressani Doldi S, Lattuada E, Zappa MA, Pieri G, Restelli A, Micheletto G. Biliointestinal bypass: another surgical option. Obes Surg 1998; 8: 566-569.
27. Boman L, Domellöf L. Biliary-intestinal bypass in the treatment of obesity: long-term follow-up. Eur J Surg 1998; 164: 943-949.
28. Micheletto G, Badiali M, Danelli PG, Sacco R, Sala B, Bressani Doldi S. The biliointestinal bypass: a thirty-years experience. Ann Ital Chir 2008; 79: 419-426.
29. Badiali M, D'Agostini A, Filippis AM, Corradini SG, Grossi A, Eramo A et al. Patency of anastomoses after bilio-intestinal bypass: radioisotope demonstration. Obes Surg 2001; 11: 615-618.
30. Favretti F, Cadiere GB, Segato G, Segato G, Bruyns G, De Marchi F et al. Laparoscopic adjustable silicone gastric banding: technique and results. Obes Surg 1995; 5: 364-371.
31. Tice JA, Karliner L, Walsh J, Petersen AJ, Feldman MD. Gastric banding or bypass? A systematic review comparing the two most popular bariatric procedures. Am J Med 2008; 121: 885-893.
32. Santry HP, Gillen DL, Lauderdale DS. Trends in bariatric surgical procedures. JAMA 2005; 294: 1909-1917.
33. Sjöström L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B et al. Lifestyle, diabetes and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004; 351: 2683-2693.
34. Vetter ML, Cardillo S, Rickels MR, Iqbal N. Narrative review: effect of bariatric surgery on type 2 diabetes mellitus. Ann Intern Med 2009; 150: 94-103.
35. Sjöström L, Narbro K, Sjöström CD, Karason K, Larsson B, Wedel H et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 2007; 357: 741-752.
36. Renehan AG, Roberts DL, Dive C. Obesity and cancer: patho-physiological and biological mechanisms. Arch Physiol Biochem 2008; 114: 71-83.
37. Gagné DJ, Papasavas PK, Maalouf M, Urbandt JE, Caushaj PF. Obesity surgery and malignancy: our experience after 1500 cases. Surg Obes Relat Dis 2008; 5: 160-164.
38. Frigè F, Laneri M, Veronelli A, Folli F, Paganelli M, Vedani P et al. Bariatric surgery in obesity: changes of glucose and lipid metabolism correlate with changes of fat mass. Nutr Metab Cardiovasc Dis 2009; 19: 198-204.
39. Després JP, Lemieux I, Bergeron J, Pibarot P, Mathieu P, Larose E et al. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol 2008; 28: 1039-1049.
40. Lee K, Lee S, Kim YJ, Kim YJ. Waist circumference, dual-energy X-ray absortiometrically measured abdominal adiposity, and computed tomographically derived intra-abdominal fat area on detecting metabolic risk factors in obese women. Nutrition 2008; 24: 625-631.
41. Nelson TL, Bessesen DH, Marshall JA. Relationship of abdominal obesity measured by DXA and waist circumference with insulin sensitivity in hispanic and non-hispanic white individuals: the San Luis Valley diabetes study. Diabetes Metab Res Rev 2008; 24: 33-40.
42. Stefan N, Kantartzis K, Machann J, Schick F, Thamer C, Rittig K et al. Identification and characterization of metabolically benign obesity in humans. Arch Intern Med 2008; 168: 1609-1616.
43. Lubrano C, Cornoldi A, Pili M, Falcone S, Brandetti F, Fabbrini E et al. Reduction of risk factors for cardiovascular diseases in morbid-obese patients following biliary-intestinal bypass: 3 years follow-up. Int J Obes Relat Metab Disord 2004; 28: 1600-1606.
44. Dixon JB, O'Brien PE. Lipid profile in the severely obese: changes with weight loss after lap-band surgery. Obes Res 2002; 10: 903-910.
45. Fruchart JC, Sacks F, Hermans MP, Assmann G, Brown WV, Ceska R et al. The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia. Am J Cardiol 2008; 102: 1K-34K.
46. Ferrannini E, Mingrone G. Impact of different bariatric surgical procedures on insulin action and beta-cell function in type 2 diabetes. Diabetes Care 2009; 32: 514-520.
47. Spanakis E, Gragnoli C. Bariatric surgery, safety and type 2 diabetes. Obes Surg 2009; 19: 363-368.
48. Purnell JQ, Flum DR. Bariatric surgery and diabetes: who should be offered the option of remission? JAMA 2009; 301: 1593-1595.
49. Guidone C, Manco M, Valera-Mora E, Iaconelli A, Gniuli D, Mari A et al. Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery. Diabetes 2006; 55: 2025-2031.
50. Parikh M, Ayoung-Chee P, Romanos E, Lewis N, Pachter HL, Fielding G et al. Comparison of rates of resolution of diabetes mellitus after gastric banding, gastric bypass, and biliopancreatic diversion. J Am Coll Surg 2007; 205: 631-635.
51. Compher C, Badellino KO. Obesity and inflammation: lessons from bariatric surgery. J Parenter Enteral Nutr 2008; 32: 645-647.
52. Anuurad E, Tracy RP, Pearson TA, Kim K, Berglund L. Synergistic role of inflammation and insulin resistance as coronary artery disease risk factors in African Americans and Caucasians. Atherosclerosis 2009; 205: 290-295.